CMS and the FDA launched the RAPID Medicare coverage pathway for devices, creating a faster route to reimbursement for qualifying medical technologies. The policy should improve commercialization timelines and reduce coverage uncertainty for device makers, making it a constructive regulatory development for the healthcare innovation sector.
CMS and the FDA launched the RAPID Medicare coverage pathway for devices, creating a faster route to reimbursement for qualifying medical technologies. The policy should improve commercialization timelines and reduce coverage uncertainty for device makers, making it a constructive regulatory development for the healthcare innovation sector.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
